{
  "DOI": "10.1007/s10689-019-00142-8",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-019-00142-8",
  "alternative-id": [
    "142"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "23 August 2019"
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-8482-5784",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Evans",
      "given": "D. Gareth",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "Sacha J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Howell",
      "given": "Anthony",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        8,
        23
      ]
    ],
    "date-time": "2019-08-23T06:02:22Z",
    "timestamp": 1566540142000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        8,
        21
      ]
    ],
    "date-time": "2020-08-21T23:19:06Z",
    "timestamp": 1598051946000
  },
  "funder": [
    {
      "DOI": "10.13039/100014653",
      "award": [
        "IS-BRC-1215-20007"
      ],
      "doi-asserted-by": "publisher",
      "name": "Manchester Biomedical Research Centre"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        8,
        22
      ]
    ],
    "date-time": "2023-08-22T11:26:06Z",
    "timestamp": 1692703566431
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2019,
        8,
        23
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2019,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            8,
            23
          ]
        ],
        "date-time": "2019-08-23T00:00:00Z",
        "timestamp": 1566518400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            8,
            23
          ]
        ],
        "date-time": "2019-08-23T00:00:00Z",
        "timestamp": 1566518400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-019-00142-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-019-00142-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-019-00142-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "377-379",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2019,
        8,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        8,
        23
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s10549-019-05345-2",
      "author": "Bernadette A. M. Heemskerk-Gerritsen",
      "doi-asserted-by": "publisher",
      "first-page": "723",
      "issue": "3",
      "journal-title": "Breast Cancer Research and Treatment",
      "key": "142_CR1",
      "unstructured": "Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI, Collée M, Meijers-Heijboer HEJ, Jenner DJ, Oldenburg HSA, van Engelen K, de Vries J, van Asperen CJ, Devilee P, Blok MJ, Kets CM, Ausems MGEM, Seynaeve C, Rookus MA, Hooning MJ (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. \n                    https://doi.org/10.1007/s10549-019-05345-2",
      "volume": "177",
      "year": "2019"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7991",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "222",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "142_CR2",
      "unstructured": "Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction. strategies for BRCA1/2 mutation carriers. J Clin Oncol 28(2):222–231",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2011.38.6060",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "142_CR3",
      "unstructured": "Kurian AW, Munoz DF, Rust P, Schackmann EA, Smith M, Clarke L, Mills MA, Plevritis SK (2012) Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol 30(5):497–506",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s13053-016-0048-3",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "issue": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "142_CR4",
      "unstructured": "https://doi.org/10.1186/s13053-016-0048-3\n                    \n                  Evans DG, Harkness EF, Howell A, Wilson M, Hurley E, Holmen MM, Tharmaratnam KU, Hagen AI, Lim Y, Maxwell AJ, Moller P (2016) Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all-cause mortality. Hered Cancer Clin Pract 14:8. \n                    https://doi.org/10.1186/s13053-016-0048-3",
      "volume": "14",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.29534",
      "author": "S Saadatmand",
      "doi-asserted-by": "publisher",
      "first-page": "1729",
      "issue": "7",
      "journal-title": "Int J Cancer",
      "key": "142_CR5",
      "unstructured": "Saadatmand S, Obdeijn IM, Rutgers EJ, Oosterwijk JC, Tollenaar RA, Woldringh GH et al (2015) Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). Int J Cancer 137:71729–1738. \n                    https://doi.org/10.1002/ijc.29534",
      "volume": "137",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ijc.23340",
      "author": "KA Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "2017",
      "issue": "9",
      "journal-title": "Int J Cancer",
      "key": "142_CR6",
      "unstructured": "Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA (2008) Hereditary Breast Cancer Clinical Study Group (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122(9):2017–2022",
      "volume": "122",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-09-0171",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "2318",
      "issue": "8",
      "journal-title": "Cancer Epid Biomark Prev",
      "key": "142_CR7",
      "unstructured": "Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A (2009) Uptake of risk reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age and time dependent. Cancer Epid Biomark Prev 18(8):2318–2324",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1038/s41416-019-0446-1",
      "author": "K Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "issue": "1",
      "journal-title": "Br J Cancer",
      "key": "142_CR8",
      "unstructured": "Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2019) International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. Br J Cancer 121(1):15–21",
      "volume": "121",
      "year": "2019"
    },
    {
      "DOI": "10.1002/1097-0142(20010815)92:4\u003c959::AID-CNCR1406\u003e3.0.CO;2-V",
      "author": "C Julian-Reynier",
      "doi-asserted-by": "publisher",
      "first-page": "959",
      "journal-title": "Cancer",
      "key": "142_CR9",
      "unstructured": "Julian-Reynier C, Bouchard L, Evans G, Eisinger F, Foulkes W, Kerr B, Blanquaert I, Moatti J-P, Sobol H (2001) Women's Attitudes toward preventive strategies for Hereditary Breast/Ovarian Cancer risk differ from one country to another: differences between Manchester (UK), Marseilles (F) and Montreal (Ca). Cancer 92:959–968",
      "volume": "92",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ejca.2013.04.025",
      "author": "M Den Heijer",
      "doi-asserted-by": "publisher",
      "first-page": "2798",
      "issue": "13",
      "journal-title": "Eur J Cancer",
      "key": "142_CR10",
      "unstructured": "Den Heijer M, van Asperen CJ, Harris H, Nippert I, Schmidtke J, Bouhnik AD, Julian-Reynier C, Evans DG, Tibben A (2013) International variation in physicians' attitudes towards prophylactic mastectomy—comparison between France, Germany, the Netherlands and the United Kingdom. Eur J Cancer 49(13):2798–2805",
      "volume": "49",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2011.40.1562",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "471",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "142_CR11",
      "unstructured": "Evans DG, Howell A (2012) Are we ready for online tools in decision making for BRCA1/2 mutation carriers? J Clin Oncol 30(5):471–3",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1038/s41416-018-0127-5",
      "author": "NM Tung",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "142_CR12",
      "unstructured": "Tung NM, Garber JE (2018) BRCA1/2 testing: therapeutic implications for breast cancer management. Br J Cancer 119(2):141–152",
      "volume": "119",
      "year": "2018"
    }
  ],
  "reference-count": 12,
  "references-count": 12,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-019-00142-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}